Participation in phase 1 trials for patients with cancer

[...]the treatment-related death risk always remained below 1% in all periods and across all cancers, except pancreatic cancer. [...]the sample size of CTEP-sponsored phase 1 studies was usually lower than those of industry-sponsored studies, increasing the risk of bias due to sparse data. Because s...

Celý popis